| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |